Biopharma MEA is a Dubai based company, specialized in the marketing and sales promotion of niche and biotech pharmaceutical products across the Middle East region.
Biopharma MEA is partnering with several multinational pharmaceutical companies, expanding their worldwide presence to the Middle East countries, allowing the patients in these countries to benefit from their advanced therapies.
Biopharma MEA is performing its functions through a group of talented and experienced dedicated teams, located across the Middle East countries, to provide optimal geographical coverage and efficient scientific detailing.
History & Background
Biopharma MEA, was founded in 2007, by Sh. Yasser Naghi, and Dr. Mohamed Ramzy. It was created as an affiliate of Cigalah Group, responsible for the marketing and sales promotion for certain niche and biotech pharmaceutical products across the Middle East region.
Cigalah Group is a leading Saudi pharmaceutical distributor, representing over 30 pharmaceutical companies in Saudi Arabia, and enjoying long experience in the pharmaceutical industry.
Biopharma MEA is focusing its activities on the marketing and sales promotion, collaborating with local distributors in each market for the required logistic activities.
Since its Creation, Biopharma MEA had successfully introduced many “New to Market” and “New in Class” products to the Middle East markets. These introductions have been done in full coordination with their partners. Over the last years they have been achieving numerous successes with their partners, putting robust milestones for new therapies in their markets and shaping the future of many existing therapeutic areas.
Where is Biopharma Middle East & Africa FZ LLC (FZ Biopharma)